Jan 30, 2025 · OSAKA, Japan and CAMBRIDGE, Massachusetts, January 30, 2025 – Takeda (TSE:4502/NYSE:TAK) announced today that its Board of Directors made the decision …

Julie Kim is president of the U.S. Business Unit, U.S. country head and member of Takeda’s Executive Team. The U.S. Business Unit portfolio encompasses gastroenterology, …

Jan 30, 2025 · CEO Christophe Weber to retire from Takeda in June 2026 after 12 years. Julie Kim, president of the U.S. Business Unit, named to succeed Weber after multi-year …

Jan 30, 2025 · Takeda has named Julie Kim as its next CEO. She will replace Christophe Weber who plans to step down in June of 2026 after leading Japan’s largest drugmaker for 11 years.

Jan 30, 2025 · About Julie Kim Julie Kim has been the president of the U.S. Business Unit and U.S. country head since 2022, and a member of the Takeda Executive Team since 2019. With …

Julie Kim is President of the U.S. Business Unit, U.S. Country Head and member of Takeda’s Executive Team. The U.S. Business Unit portfolio encompasses gastroenterology, …

Takeda Pharmaceutical named Julie Kim, who heads its U.S. business, as its new chief executive starting in 2026, elevating her to the small but growing ranks of women leading Japanese …

Jan 30, 2025 · CEO Christophe Weber to retire from Takeda in June 2026 after 12 years Julie Kim, president of the U.S. Business Unit, named to succeed Weber after multi-year …

Jan 30, 2025 · Julie Kim is set to replace Christophe Weber as the new CEO of Takeda Pharmaceutical, becoming the first woman to lead the more than 240-year-old Japanese …

Jan 30, 2025 · Julie Kim is set to replace Christophe Weber as the new chief executive officer of Takeda Pharmaceutical Co., becoming the first woman to lead the more than 240-year-old …